Rekvina Laboratories Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1988.
1988 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Rekvina Laboratories Limited

Rekvina Laboratories Limited, a active public limited company, was established on 01 November 1988 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231GJ1988PLC011458. Registered under ROC Roc Ahmedabad. it is listed on BSE: 526075. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.01 Cr.

Formerly known as Rekvina Laboratories Private Limited. It upholds a active non-compliant status. In 2023, it reported revenue of ₹37.62 K and a net worth of ₹0.13 M. Its leadership includes Dhruvalkumar Jayantilal Patel (Director), Prateek Jain (Additional Director), Mahendra Shantilal Dalal (Additional Director). Past directors included Dhruvalkumar Jayantilal Patel, Jitendra Laljibhai Doshi, Mahendra Shantilal Dalal. It holds ₹8.04 Cr open charges and no settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 36, Sampatrao Colony,, Next To Royal Hotel,, Vadodara, Gujarat, 390007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24231GJ1988PLC011458

  • Registration Number

    011458

  • Incorporation Date

    01 November 1988

  • Authorized Capital

    ₹3.50 Cr

  • Paid-Up Capital

    ₹3.01 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 526075)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 Cr
  • Paid Up Capital ₹ 3.01 Cr
  • Company Age 37 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.04 Cr
  • Revenue Growth **** %
  • Profit Growth **** 99.06%
  • Ebitda **** 94.62%
  • Net Worth -5.36%
  • Total Assets **** 4.92%
Company report

Rekvina Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rekvina Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rekvina Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Dhruvalkumar Jayantilal Patel Director 02 Sep 2024 Current
Prateek Jain Additional Director 06 Oct 2025 Current
Mahendra Shantilal Dalal Additional Director 01 Oct 2010 Current
Surbhit Mukesh Shah Cfo 02 Sep 2024 Current
Chetanbhai Jayantibhai Patel Director 02 Sep 2024 Current
Vibha Mukesh Shah Director 21 Mar 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Sep 2024 Past
Pramod Abcsdd Additional Director 28 Nov 2025 Past
Pramod Abcsdd Additional Director 22 Jun 2024 Past
Pramod Abcsdd Director 01 Oct 2010 Past
Pramod Abcsdd Additional Director 26 Sep 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rekvina Laboratories.

Rekvina Laboratories Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.06% increase in profit. The company's net worth dipped by a decrease of 5.36%.

Rekvina Laboratories revenue growth over time
Rekvina Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 4.92%
*******
*******
*******
*******
Profit or Loss
*******
 99.06%
*******
*******
*******
*******
Net Worth
*******
 -5.36%
*******
*******
*******
*******
EBITDA
*******
 94.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rekvina Laboratories?

In 2023, Rekvina Laboratories had a promoter holding of 41.30% and a public holding of 58.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹80,395,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 6.95 Cr
  • Industrial Devlopment Bank Of India : 0.80 Cr
  • Gujrat State Financial Corportion : 0.29 Cr
Latest Charge Details
Date Lender Amount Status
30 Dec 2203 Bank Of Baroda ₹0.50 M Open
13 Jul 1999 Bank Of Baroda ₹1.90 Cr Open
24 Sep 1997 Bank Of Baroda ₹1.90 Cr Open
13 Jul 1994 Bank Of Baroda ₹1.90 Cr Open
10 Dec 1993 Bank Of Baroda ₹5.30 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Rekvina Laboratories?

Unlock and access historical data on people associated with Rekvina Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rekvina Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rekvina Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rekvina Laboratories
Recent Activity within the Organization
  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 0.05 Cr with Charge ID 90100140 was registered on 30 Dec 2203. was documented.

  • Director Appointment

    Progress on Prateek Jain was appointed as a Additional Director was appointed as a Additional Director on 06 Oct 2025 & has been associated with this company since 4 months 28 days . was documented.

  • Annual General Meeting

    The activity Rekvina Laboratories Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Rekvina Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Surbhit Mukesh Shah was appointed as a Cfo was appointed as a Cfo on 17 Dec 2024 & has been associated with this company since 1 year 2 months . was completed.

  • Director Appointment

    The activity Dhruvalkumar Jayantilal Patel was appointed as a Director was appointed as a Director on 02 Sep 2024 & has been associated with this company since 1 year 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rekvina Laboratories Limited?

The CIN of Rekvina Laboratories Limited is L24231GJ1988PLC011458.

Where is Rekvina Laboratories Limited headquartered?

Rekvina Laboratories Limited is headquartered at 36, Sampatrao Colony,, Next To Royal Hotel,, Vadodara, Gujarat, 390007.

When was Rekvina Laboratories Limited incorporated?

Rekvina Laboratories Limited was incorporated on 01 November 1988.

Who are the current directors of Rekvina Laboratories Limited?

The current directors of Rekvina Laboratories Limited are

What is the primary industry of Rekvina Laboratories Limited?

The primary industry of Rekvina Laboratories Limited is Manufacturing.

Is Rekvina Laboratories Limited a listed company?

Rekvina Laboratories Limited is listed. It is listed on BSE: 526075.

What is the capital structure of Rekvina Laboratories Limited?

The authorized capital of Rekvina Laboratories Limited is ₹3.50 Cr, and the paid-up capital is ₹3.01 Cr.

What is the compliance status of Rekvina Laboratories Limited?

The compliance status of Rekvina Laboratories Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available